What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His main research concerns Transplantation, Internal medicine, Surgery, Immunology and Hematopoietic stem cell transplantation.
The various areas that Nicolaus Kröger examines in his Transplantation study include Leukemia, Stem cell, Myelodysplastic syndromes and Multiple myeloma.
The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
His Surgery study combines topics in areas such as Hazard ratio and Confidence interval.
His work in the fields of Immunotherapy, Myelofibrosis, Cancer/testis antigens and T cell overlaps with other areas such as Decitabine.
His Hematopoietic stem cell transplantation research includes elements of Chemotherapy regimen, Acute leukemia, Intensive care medicine, Transplantation Conditioning and Risk factor.
His most cited work include:
- Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (273 citations)
- Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia (219 citations)
- Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report (195 citations)
What are the main themes of his work throughout his whole career to date?
Nicolaus Kröger spends much of his time researching Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Stem cell.
His study in Transplantation is interdisciplinary in nature, drawing from both Immunology, Myelofibrosis, Bone marrow and Multiple myeloma.
Nicolaus Kröger interconnects Gastroenterology and Surgery in the investigation of issues within Internal medicine.
As a part of the same scientific family, Nicolaus Kröger mostly works in the field of Hematopoietic stem cell transplantation, focusing on Leukemia and, on occasion, Myeloid.
His Oncology research includes themes of Chemotherapy, Myeloid leukemia, Survival analysis, Chronic lymphocytic leukemia and Acute leukemia.
In the field of Stem cell, his study on Haematopoiesis overlaps with subjects such as In patient.
He most often published in these fields:
- Transplantation (67.53%)
- Internal medicine (66.62%)
- Hematopoietic stem cell transplantation (33.23%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (66.62%)
- Transplantation (67.53%)
- Oncology (30.80%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Transplantation, Oncology, Stem cell and Hematopoietic stem cell transplantation.
His research investigates the link between Internal medicine and topics such as Gastroenterology that cross with problems in Cumulative incidence.
His Transplantation study combines topics from a wide range of disciplines, such as Hematopoietic cell, Myeloid leukemia, Disease, Myelofibrosis and Acute leukemia.
Nicolaus Kröger combines subjects such as Haematopoiesis, Refractory, Regimen, Chronic lymphocytic leukemia and Multiple myeloma with his study of Oncology.
The concepts of his Stem cell study are interwoven with issues in Idelalisib and Immune system.
His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Myelodysplastic syndromes, Immunology, Cohort study and Risk factor.
Between 2019 and 2021, his most popular works were:
- Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (63 citations)
- The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. (57 citations)
- Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN) (48 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Nicolaus Kröger focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Disease.
The study incorporates disciplines such as Myeloid, Myeloid leukemia, Stem cell, Hazard ratio and Myelofibrosis in addition to Transplantation.
His Oncology research incorporates themes from Chronic lymphocytic leukemia, Hematopoietic cell and Chimeric antigen receptor, Cytokine release syndrome.
His study on Allogeneic hematopoietic stem cell transplant is often connected to Viral dynamics as part of broader study in Hematopoietic stem cell transplantation.
His studies deal with areas such as Bone marrow and Intensive care medicine as well as Disease.
Nicolaus Kröger has researched Cumulative incidence in several fields, including Gastroenterology, Refractory and Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
